Report : A-Z CDF items in Formulary 18/01/2021 13:38:34
[
Back
]
Section
Status
CDF
Name
08.03.04.02
Formulary
Abiraterone Zytiga
®
08.02.03
Formulary
Atezolizumab Tecentriq
®
08.02.04
Formulary
Axicabtagene ciloleucel YESCARTA
®
08.01.01
Formulary
Bendamustine
08.01.05
Formulary
Bevacizumab
08.01.05
Formulary
Bortezomib Velcade
®
08.01.05
Formulary
Brentuximab vedotin Adcetris
®
08.01.05
Formulary
Cemiplimab
08.01.05
Formulary
Cetuximab Erbitux
®
08.01.05
Formulary
Daratumumab Darzalex
®
08.01.05
Formulary
Dasatinib Sprycel
®
08.01.02
Formulary
Doxorubicin Hydrochloride Lipid formulation
08.01.05
Formulary
Durvalumab
08.01.05
Formulary
Ibrutinib Imbruvica
®
08.01.05
Restricted Use
Ixazomib
08.02.03
Formulary
Nivolumab Opdivo
®
08.01.05
Formulary
Osimertinib
08.01.05
Formulary
Panitumumab Vectibix
®
08.01.05
Formulary
Pembrolizumab Keytruda
®
08.01.03
Formulary
Pemetrexed Alimta
®
16.02
Formulary
Radium-223 Xofigo
®
01.01
Formulary
Remote Control Panasonic
®
08.01.05
Formulary
Rucaparib Rubraca
®
08.01.05
Formulary
Sorafenib Nexavar
®
08.01.05
Formulary
Sunitinib Sutent
®
08.01.05
Formulary
Temsirolimus Torisel
®
08.01.05
Formulary
Tisagenlecleucel Kymriah
®
08.01.05
Formulary
Venetoclax Venclyxto
®
Birmingham, Sandwell, Solihull and environs APC Formulary